These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 321347)

  • 41. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
    Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
    Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surface immunoglobulins in human chronic leukemia cells.
    Harłozińska A; Noworolska A; Richter R; Becker M
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):127-43. PubMed ID: 6774692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fc receptor heterogeneity: immunofluorescent studies of B, T, and "third population" lymphocytes in human blood with rabbit IgG b4/anti-b4 complexes.
    Winfield JB; Lobo PI; Hamilton ME
    J Immunol; 1977 Nov; 119(5):1778-84. PubMed ID: 334969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Null cells in the mouse possess membrane immunoglobulins.
    Warr GW; Lee JC; Marchalonis JJ
    J Immunol; 1978 Nov; 121(5):1767-72. PubMed ID: 361890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin synthesis by neoplastic B lymphocytes: free light chain synthesis as a marker of B cell differentiation.
    Hannam-Harris AC; Gordon J; Smith JL
    J Immunol; 1980 Nov; 125(5):2177-81. PubMed ID: 6776188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.
    Stevenson GT; Elliott EV; Stevenson FK
    Fed Proc; 1977 Aug; 36(9):2268-71. PubMed ID: 69552
    [No Abstract]   [Full Text] [Related]  

  • 47. Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen.
    Gordon J; Stevenson GT
    Immunology; 1981 Jan; 42(1):13-7. PubMed ID: 6970171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
    Raso V; Griffin T
    J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of surface immunoglobulin on murine B lymphocytes.
    Parkhouse RM; Hunter IR; Abney ER
    Immunology; 1976 Mar; 30(3):409-12. PubMed ID: 815176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced modulation of antibodies coating guinea pig leukemic cells in vitro and in vivo. The role of Fc gamma R expressing cells.
    Lane AC; Foroozan S; Glennie MJ; Kowalski-Saunders P; Stevenson GT
    J Immunol; 1991 Apr; 146(7):2461-8. PubMed ID: 1826021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.
    Bona CA; Fauci AS
    J Clin Invest; 1980 Mar; 65(3):761-7. PubMed ID: 6986413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants.
    Stevenson FK; Elliott EV
    Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
    Haegert DG
    Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence of surface IgM, IgD, and free light chains of human lymphocytes.
    Fu SM; Winchester RJ; Kunkel HG
    J Exp Med; 1974 Feb; 139(2):451-6. PubMed ID: 4589993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes.
    Spiegelberg HL; Dainer PM
    Clin Exp Immunol; 1979 Feb; 35(2):286-95. PubMed ID: 312174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):585-91. PubMed ID: 1079034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement receptor lymphocytes. Analysis of immunoglobin on their surface and further evidence of heterogeneity.
    Arnaiz-Villena A; Hay FC
    Immunology; 1975 Apr; 28(4):719-29. PubMed ID: 1097333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surface-bound immunoglobulin on B-lymphocytes, evidence for allelic exclusion.
    Natvig JB; Froland SS
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):281-6. PubMed ID: 4142558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.